Back

Re: Shahim et al., 2024 “Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction”

European Heart Journal - Cardiovascular Pharmacotherapy

28 May 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY
You may be interested in
thumbnail
Congress Presentation
Potential cardioprotective effects of acetylcholinesterase inhibitors in patients with Alzheimer's disease
27 August 2023
thumbnail
Congress Presentation
Less revascularization and increased in-hospital mortality in patients with schizophrenia spectrum disorder after myocardial infarction
31 August 2025
thumbnail
Congress Presentation
Real-world impact on mortality of drug adherence to statin, beta-blocker and ACEi/ARB therapy in post-STEMI patients with preserved EF: results from the FAST STEMI registry.
26 August 2023
thumbnail
Congress Presentation
Controversies in acute cardiovascular care in the elderly: ethics and evidence – discussion.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources